Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHgCapital Trust plc Regulatory News (HGT)

Share Price Information for HgCapital Trust plc (HGT)

Share Price is delayed by 15 minutes
Get Live Data
399.50    -1.50 (-0.37%)
Bid:
400.00
Ask:
400.50
Spread: 0.50 (0.125%)
Market Cap: £1.81b
HGT Live PriceLast checked at - London Stock Exchange

Intraday HgCapital Trust plc Share Chart

Acquisition

4 May 2010 07:00

RNS Number : 2064L
HG Capital Trust PLC
04 May 2010
 



Set out below is the text of a press release issued today by HgCapital, which manages the investment portfolio of HgCapital Trust plc alongside those of other institutional clients. The Trust, which is a listed investment trust giving private and institutional investors the opportunity to participate in all HgCapital's investments, will invest approximately £12.0 million in Frösunda.

HgCapital acquires Frösunda from Polaris

 

London, 4 May 2010: HgCapital, the European sector focused private equity investor, is pleased to announce that it has agreed the acquisition of Frösunda LSS AB, the leading Swedish provider of specialist disability care. The transaction is subject to regulatory approval. The company has been acquired from Polaris, the Danish private equity firm. The value of the transaction was undisclosed.

 

Frösunda, headquartered in Solna, Sweden, was originally a subsidiary of the health care services co-operative, Praktikertjänst. It became an independent business, backed by Polaris, in 2007. Frösunda provides personal assistance (care delivered to the home) and housing (group assisted accommodation) services for adults and children with physical or mental disabilities. It also has an emerging coaching and schools business. Frösunda cares for 1,600 users and operates 41 offices across Sweden.

 

HgCapital will be working with the existing management team to continue to develop Frösunda as an independent business and the leading provider of specialist care in Sweden. HgCapital fully supports management's strategic objectives of maintaining organic growth, continuing to grow by acquisition and further investment to diversify the company's care offering.

 

This transaction is the second investment made by HgCapital's specialist healthcare sector team in the last six months. Carl Harring executed the transaction for HgCapital as part of an exclusive bid process.

 

Commenting on the acquisition, Lindsay Dibden, Partner of HgCapital and Head of the Healthcare team stated: "The HgCapital healthcare team has followed the Scandinavian market for several years based on the favourable macro demographics, high quality companies, and the strong trend towards outsourcing. Our sector experience and knowledge of Nordic investing meant we were able to proactively identify the key sub sectors we wish to deploy capital in, namely specialist care.

 

Carl Harring, who led the transaction for HgCapital added,"Frösunda provides the broadest care offering in the Swedish specialist care market and has an excellent management team. This investment represents an attractive opportunity to build on the company's impressive track record in its current markets and to enable it to expand its care offering into adjacent segments."

 

Göran Fredriksson, CEO of Frösunda added:"Over recent years Frösunda has undergone extensive re-organisation and established an excellent reputation in delivering the highest quality of care in Sweden. We are pleased to be able to draw on HgCapital's sector expertise and financial backing in working towards the next stage in the company's evolution."

 

- Ends -

 

 

For further details:

HgCapital

Carl Harring

+44 (0)20 7089 7935

Maitland

Neil Bennett

+44 (0)20 7379 5151

Rowan Brown

+44 (0)20 7379 5151

 

 

About HgCapital

 

HgCapital is a sector focused private equity investor in the European mid-market. We focus on investments with an enterprise value in the range of £50-£500 million. Our business model combines sector specialisation with dedicated, pro-active support to our portfolio companies as well as the corresponding management expertise across all phases of the investment process.

HgCapital manages £3 billion for some of the world's leading institutional and private investors.

For further details, see www.hgcapital.com 

 

 

About HgCapital Trust plc

 

HgCapital Trust plc is an investment trust whose shares are listed on the London Stock Exchange. The trust gives investors exposure to a portfolio of high-growth private companies, through a liquid vehicle. This portfolio is managed by HgCapital, an experienced and well-resourced private equity firm with a long-term track record of delivering superior risk-adjusted returns for its investors. The Trust has won the Investment Week Private Equity Investment Trust of the Year every year since 2005.

 

For further details, see www.hgcapitaltrust.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQURONRRUASOAR
Date   Source Headline
17th Aug 20238:00 amRNSHg agrees to partial sale of TeamSystem
4th Aug 20237:15 amRNSEdison issues review on HG Capital Trust (HGT)
20th Jul 20237:00 amRNSHg announces investment in Nomadia
19th Jun 20237:00 amRNSAzets Group secures investment from PAI to join Hg
18th May 20239:00 amRNSHg announces investment in GTreasury
17th May 20235:21 pmRNSResult of AGM
15th May 20237:00 amRNSQ1 2023 Report to 31 March 2023
12th May 20234:53 pmRNSBlock listing Interim Review
4th Apr 202310:04 amRNSDirector/PDMR Shareholding
3rd Apr 20233:51 pmRNSUpdate on HGT's Commitment to Hg's Saturn 3 Fund
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 202310:35 amRNSDirector/PDMR Shareholding
28th Mar 202312:24 pmRNSDirector/PDMR Shareholding
16th Mar 20232:14 pmRNSHgCapital Trust results summary with Doceo
15th Mar 202310:55 amRNSDirector/PDMR Shareholding
13th Mar 202310:51 amRNSUpdate on Silicon Valley Bank
13th Mar 20237:00 amRNSAnnual Results & Notice of Annual General Meeting
13th Mar 20237:00 amRNSAnnual Financial Report
31st Jan 20234:50 pmRNSBlock listing Interim Review
13th Dec 20227:00 amRNSHg agrees to sale of Transporeon
16th Nov 20227:00 amRNSEdison issues update on HgCapital Trust (HGT)
14th Nov 20227:00 amRNS3rd Quarter Results
1st Nov 202210:10 amRNSTotal Voting Rights
14th Oct 20227:00 amRNSTransaction in Own Shares
5th Oct 20227:00 amRNSIdeagen and ProcessMAP to Combine
4th Oct 20228:25 amRNSTrustQuay Secures Hg Investment
4th Oct 20227:00 amRNSTrustQuay Secures Hg Investment
13th Sep 20227:46 amRNSEdison issues update on HgCapital Trust (HGT)
12th Sep 20227:00 amRNSHgCapital Trust Interim Results 2022
12th Sep 20227:00 amRNSHalf-year Report
2nd Aug 20223:38 pmRNSHolding(s) in Company
20th Jul 20225:50 pmRNSHolding(s) in Company
14th Jul 20221:00 pmRNSHg announces a partial sale of Intelerad
7th Jul 20224:40 pmRNSReplacement: Director/PDMR Shareholding
6th Jul 20227:30 amRNSHg announces further investment in team.blue
5th Jul 20221:43 pmRNSDirector/PDMR Shareholding
4th Jul 20225:18 pmRNSDirector/PDMR Shareholding
28th Jun 20224:00 pmRNSNorstella announces merger agreement with Citeline
24th Jun 20227:00 amRNSHGT Board note agreement on acquisition of Ideagen
14th Jun 20227:00 amRNSHg agrees sale of MEDIFOX DAN to ResMed for US$1bn
9th Jun 20223:56 pmRNSInvestment in TigerRisk Partners
8th Jun 20227:00 amRNSHg further invests in The Access Group
17th May 20226:00 pmRNSHg agrees the sale of itm8 to Axcel
17th May 20227:00 amRNSEdison issues review on HgCapital Trust (HGT)
13th May 20224:54 pmRNSBlock listing Interim Review
10th May 20225:34 pmRNSResult of AGM
9th May 20227:00 amRNS1st Quarter Results
3rd May 20223:23 pmRNSAGM Update - Withdrawal of AGM Resolution
29th Apr 20221:38 pmRNSDirectorate Change
11th Apr 20223:00 pmRNSHg announces investment in LucaNet

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.